Impairment of bone mass development in children with chronic cholestatic liver disease

Clinical Endocrinology

Volumn 66, Issue 4, 2007, Pages 518-523

  De Albuquerque Taveira, Adriana Távora ^a   Fernandes, Maria Inez Machado ^a   Galvão, Lívia Carvalho ^a   Sawamura, Regina ^a   De Mello Vieira, Enaldo ^a   De Paula, Francisco José Albuquerque ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BONE AGE; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE MINERAL; BONE REMODELING; CHILD; CHILDHOOD DISEASE; CHOLESTATIC HEPATITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL DISORDER; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP RADIOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; LUMBAR SPINE; MALE; MATHEMATICAL ANALYSIS; MINERAL METABOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; URINE LEVEL; VITAMIN BLOOD LEVEL; WHOLE BODY IMAGING;

ADOLESCENT; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BODY HEIGHT; BONE DENSITY; BONE DEVELOPMENT; BONE REMODELING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTASIS, INTRAHEPATIC; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; LUMBAR VERTEBRAE; MALE; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

EID: 33947249674     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02765.x     Document Type: Article

References (32)

1. Idilman, R., De Maria, N., Uzunalimoglu, O. & Van Thiel, D.H. (1997) Hepatic osteodystrophy: a review. Hepatogastroenterology, 44, 574-581.
2. D'Antiga, L., Miniz, C., Buxton-Thomas, M., Cheeseman, P., Gray, B., Abraha, H., Baker, A.J., Heaton, N.D., Mieli-Vergani, G. & Dhawan, A. (2002) Bone mineral density and height gain in children with chronic cholestatic liver disease undergoing transplantation. Transplantation, 73, 1788-1793.
3. Ormarsdóttir, S., Ljunggren, O., Mallmin, H., Michaelsson, K. & Loof, L. (2002) Increased rate of bone loss at the femoral neck in patients with chronic liver disease. European Journal of Gastroenterology and Hepatology, 14, 43-48.
4. Leslie, W.D., Bernstein, C.N. & Leboff, M.S. (2003) AGA technical review on osteoporosis in hepatic disorders. Gastroenterology, 125, 941-966.
5. Hay, J.E. (1995) Bone disease in cholestatic liver disease. Gastroenterology, 108, 276-283.
6. Argao, E.A., Specker, B.L. & Heubi, J.E. (1993) Bone mineral content in infants and children with chronic cholestatic liver. Pediatrics, 91, 1151-1154.
7. Toki, A., Todani, T., Watanabe, Y., Sato, Y., Ogura, K., Yoshikawa, M., Yamamoto, S. & Wang, Z.Q. (1997) Bone mineral analysis in patients with biliary atresia after successful Kasai procedure. Tohoku Journal of Experimental Medicine, 181, 213-216.
8. Klein, G.L., Soriana, K.G.L., Shulmana, R.J., Levy, M., Jones, G. & Langman, C.B. (2002) Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiology. Pediatric Transplantation, 6, 136-140.
9. Guichelaar, M.M.J., Malinchoc, M., Sibonga, J., Clarke, B.L. & Hay, J.E. (2002) Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology, 36, 895-903.
10. Argao, E.A., Balistreri, W.F., Hollis, B.W., Ryckman, F.C. & Heubi, J.E. (1994) Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis. Hepatology, 20, 598-603.
11. Guthery, S.L., Pohl, J.F., Bucuvalas, J.C., Alonso, M.H., Rykman, F.C., Balistreri, W.F. & Heubi, J.E. (2003) Bone mineral density in long-term survivors following pediatric liver transplantation. Liver Transplantation, 9, 365-370.
12. Crosbie, O.M., Freaney, M.J. & Hegarty, J.E. (1999) Bone density, vitamin D status and disordered bone remodeling in end-stage chronic liver disease. Calcified Tissue International, 64, 295-300.
13. Chen, C.C., Wang, S.S., Jeng, F.S. & Lee, S.D. (1996) Metabolic bone disease of liver cirrhosis: is it parallel to clinical severity of cirrhosis? Journal of Gastroenterology and Hepatology, 11, 417-421.
14. Bucuvalas, J.C., Horn, J.A., Slusher, J., Alfaro, M.P. & Chernausek, S.D. (1996) Growth hormone insensitivity in children with biliary atresia. Journal of Pediatric Gastroenterology and Nutrition, 23, 135-140.
15. Carter, D.R., Louxsein, M.L. & Marcus, R. (1992) New approaches for interpreting projected bone densitometry data. Journal of Bone and Mineral Research, 7, 137-145.
16. Kanis, J.A., Delmas, P., Burckhardt, C., Cooper, C. & Torgerson, D. (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporosis International, 7, 390-406.
17. Matkovic, D. (1996) Skeletal development and bone turnover revisited. Journal of Clinical Endocrinology and Metabolism, 81, 2013-2015.
18. Soyka, L.A., Fairfield, W.P. & Klibanski, A. (2000) Hormonal determinants and disorders of peak bone mass in children. Journal of Clinical Endocrinology and Metabolism, 85, 3951-3963.
19. Leonard, M.B., Propert, K.J., Zemel, B.S., Stallings, V.A. & Feldman, H.I. (1999) Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. The Journal of Pediatrics, 135, 182-188.
20. Janz, K. (2002) Physical activity and bone development during childhood and adolescence: implications for the prevention of osteoporosis. Minerva Pediatrica, 54, 93-104.
21. Takahashi, Y., Minamitani, K., Kobayashi, Y., Minagawa, M., Tasuda, T. & Niimi, H. (1996) Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism. Journal of Clinical Endocrinology and Metabolism, 81, 1248-1253.
22. Lu, P.W., Cowell, C.T., Lloyd-Jones, A.S., Briody, J.N. & Howman-Giles, R. (1996) Volumetric bone mineral density in normal subjects, aged 5-27 years. Journal of Clinical Endocrinology and Metabolism, 81, 1586-1590.
23. Kroger, H., Kotaniemi, A., Kroger, L. & Alhava, E. (1993) Development of bone mass and bone density of the spine and femoral neck - a prospective study of 65 children and adolescents. Bone and Mineral, 23, 171-182.
24. Katzman, D.K., Bachrach, J.K., Carter, D.R. & Marcus, R. (1991) Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. Journal of Clinical Endocrinology and Metabolism, 73, 1332-1339.
25. Okajima, H., Shigeno, C., Inomata, Y., Egawa, H., Uemoto, S., Asonuma, K., Kiuchi, T., Konishi, J. & Tanaka, K. (2003) Long-term effects of liver transplantation on bone mineral density in children with end-stage liver disease: a 2-year prospective study. Liver Transplantation, 9, 360-364.
26. Yoshida, S., Nio, M., Hayashi, Y., Ohi, R., Kawamura, I. & Osaka, T.G. (2003) Serum insulin-like growth factor-I in biliary atresia. Journal of Pediatric Surgery, 38, 211-215.
27. Sjogren, K., Jansson, J.O., Isaksson, O. & Ohlsson, C. (2002) A model for tissue-specific inducible insulin-like growth factor I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine, 19, 249-256.
28. Yakar, S., Rosen, C.J., Beamer, W.G., Arkert-Bicknell, C.L., Wu, Y., Liu, J.L., Ooi, G.T., Setser, J., Frustyk, J., Boisclair, Y.R. & Leroith, D. (2002) Circulating levels of IGF-1 directly regulate bone growth and density. Journal of Clinical Investigation, 110, 771-781.
29. Rouillard, S. & Lane, N.E. (2001) Hepatic osteodystrophy. Hepatology, 33, 301-307.
30. Janes, C.H., Dickson, E.R., Okazaki, R., Bonde, S., Mcdonagh, A.F. & Riggs, B.L. (1995) Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. Journal of Clinical Investigation, 95, 2581-2586.
31. Chongsrisawat, Y., Ruttanamongkol, P., Chaiwatanarat, T., Chandrakamol, B. & Poovorawan, Y. (2001) Bone density and 25-hydroxyvitamin D level in extrahepatic biliary atresia. Pediatric Surgery International, 17, 604-608.
32. Smith, D.L., Shire, N.J., Watts, N.B., Schmitter, T., Szabo, G. & Zucker, S.D. (2006) Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. Journal of Clinical Densitometry, 9, 105-113.